New Single-Incision breast reconstruction could reduce scars and improve satisfaction

NCT ID NCT07257003

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviews 150 breast cancer patients who had a delayed breast reconstruction using a new endoscopic technique through a small armpit incision, at least 6 months after their mastectomy. The goal is to see if this method leads to better patient satisfaction and fewer complications compared to traditional approaches. Researchers will analyze surgical outcomes, aesthetic results, and safety data from multiple hospitals across the country.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
delayed endoscopic direct-to-implant breast reconstruction via axillary approach
What this could lead to
If successful, this could offer a less invasive, single-operation breast reconstruction option with better cosmetic results and fewer scars for women who have had a mastectomy.
What could go wrong
This is a retrospective study, meaning it looks back at past data, not a controlled trial. Results may not apply to all patients, and the procedure carries risks like infection, bleeding, or flap issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • West China hospital of Sichuan University

    Chengdu, Sichuan, 610000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.